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ABSTRACT
INCREASED BODY WEIGHT IN ADULTHOOD FOLLOWING A PERIPUBERTAL
STRESSOR AND PROPOSED MECHANISM FOR EFFECTS OF INCREASED
ADIPOSITY ON ESTROGEN-DEPENDENT BEHAVIORS
SEPTEMBER 2014
CHRISTINA FELDER GAGLIARDI, B.A., MOUNT HOLYOKE COLLEGE
B.S., UNIVERSITY OF MAINE ORONO
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by Jeffrey D. Blaustein
Exposure to certain stressors during a sensitive period around puberty can lead to
enduring effects on an animal’s response to estradiol. In estradiol-influenced behaviors,
such as sexual receptivity, hippocampal-dependent learning and memory, depression-like
behavior, and anxiety-like behaviors, exposure to a peripubertal stressor such as shipping
stress or an injection of lipopolysaccharide (LPS) can eliminate or even reverse the
normal response to estradiol. In addition to regulating these behaviors, estradiol play a
role in the regulation of body weight. While some of the previous studies touched on
short-term effects on body weight, no systemic long-term study of the effects of a
peripubertal stressor on body weight, particularly without interruption by ovariectomy,
have been undertaken. This paper introduces a hypothesis that proposes that increased
adiposity following exposure to a peripubertal stressor leads to the changes to estrogendependent behaviors through altered levels of estrogens and changes to estrogen
receptors. The first chapter examines body weight data collected during studies with
other aims, and then proposes an experiment to test whether either of two peripubertal
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stressors results in increased weight gain and body weight. The following chapter
proposes further experiments designed to determine the proximate mechanisms leading to
weight gain following peripubertal stressors and the role of diet on weight gain. The final
chapter proposes experiments to test the effects of adiposity on peripheral levels of
testosterone, aromatase, estradiol, and estrone; central levels of estradiol and estrone; and
estrogen receptors in the brain.
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CHAPTER 1
THE SENSITIVE PERIPUBERTAL PERIOD, STRESS, ESTRADIOLINFLUENCED BEHAVIORS, AND OBESITY: BACKGROUND AND
HYPOTHESIS
Previous findings from the Blaustein laboratory
Introduction
Exposure to certain stressors during a sensitive period around puberty can lead to
enduring effects on an animal’s response to estradiol. Specifically, exposure to a
peripubertal stressor can eliminate or even reverse the normal response to estradiol for a
variety of behaviors, including sexual receptivity, hippocampal-dependent learning and
memory, depression-like behavior, and anxiety-like behaviors. This effect was first
examined and established in the Blaustein laboratory, with a series of papers published
beginning in 2009. Work on this phenomenon continues in the laboratory with
exploration on multiple levels into the mechanisms by which these changes occur. This
section will review the major papers from the lab, in the order in which they were
published, as well as give a brief mention to preliminary findings from studies in
progress. It will conclude with a short summary of the findings thus far.
Establishment of the sensitive peripubertal period
The initial work establishing an effect of peripubertal stressors on sexual
receptivity in response to exogenous hormones tested sex, age, and different stressors.
This initial work was published in two papers (Laroche, Gasbarro, Herman, & Blaustein,
2009a, 2009b) and all completed in C57Bl/6 mice. Female mice were all ovariectomized
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and administered estradiol benzoate and progesterone weekly before sexual behavior
testing. Sexual behavior testing was conducted weekly for five weeks, beginning the
week after ovariectomy. Sexual receptivity was measured by assessing the animal’s
lordosis quotient, or the number of times that the female exhibited a lordosis posture in
response to a mount from a male mouse.
Laroche et al. first established that female mice shipped at 6 weeks of age have
significantly reduced sexual receptivity after ovariectomy followed by injections of
estradiol and progesterone than mice shipped at 12 weeks or animals bred in the
laboratory (Laroche et al., 2009b). These differences in sexual receptivity are not due to
differences in age of behavior testing; female mice shipped at 6 weeks and tested
beginning at 8 or 14 weeks each show significantly reductions in lordosis quotient
contrasted with animals shipped at 12 weeks and tested beginning at 14. The sensitive
period was identified by examining mice shipped at 3, 4, 5, 6, 7, 8, 9, 10, and 12 weeks of
age and tested beginning at week 14. Mice shipped at 6 weeks showed lower sexual
receptivity than those shipped at ages of 7 weeks or more. The mice shipped at 6 weeks
also showed decreased sexual receptivity compared with those mice shipped at 3 or 4, but
only in the fifth test session. No difference was detected between mice shipped at 5 or 6
weeks. Corticosterone response was assessed after each behavior test session by
examining plasma corticosterone levels. Corticosterone decreased with each additional
week of testing for both 6 week and 12 week shipped animals; the only difference found
between animals shipped at 6 and 12 weeks was following the first week of testing when
12 week animals had a significantly higher corticosterone level. In conclusion this paper
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established that the effects of shipping on sexual receptivity are specific to female mice
shipped at 5 or 6 weeks.
The second publication (Laroche et al., 2009a), addressed other peripubertal
stressors and their short-term effects on corticosterone levels and body weight and any
enduring effects on sexual receptivity. Restraint stress, food deprivation, and a multiple
stressor paradigm (three daily bouts of restraint under bright light) increased plasma
corticosterone levels in response to the stressor after some or all applications of the
stressor. These three stressors decreased body weight as measured for several hours to
several days following the stressor. While animals from all three stress paradigms
showed an increase in sexual receptivity by week of testing (increased receptivity with
additional tests), there were no differences between stressed individuals and controls.
Injections of several concentrations of lipopolysaccharide (LPS), a bacterial endotoxin
from the cell membrane of Escherichia coli, increased plasma corticosterone levels,
although only the highest dose (1.5mg/kg body weight) significantly decreased sexual
receptivity over several test sessions. This highest dose of LPS specifically decreases
sexual receptivity on the third, fourth, and fifth test sessions. Finally, animals were
injected with the high dose of LPS at 3, 4, 5, 6, 7, 8, and 10 weeks of age and tested for
sexual receptivity in order to determine the sensitive window. Animals injected at 3,7, 8,
and 10 weeks showed no decrease in sexual receptivity when compared to controls.
Those animals injected at 4 and 5 weeks decreased during only one or two test sessions,
while animals injected at 6 weeks significantly decreased sexual receptivity for the third,
fourth, and fifth test sessions. In summary this paper revealed that the effects of
peripubertal stressor on sexual receptivity are dependent on the type of stressor and that
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an injection of a high dose of LPS at 6 weeks results in decreased sexual receptivity in
response to estradiol.
Further investigations of effects of peripubertal stressors
Following the initial publications, research extended to include effects on other
estradiol-influenced behaviors including anxiety-like behavior, depression-like behavior,
and memory in female mice. These studies were conducted either in C57Bl/6 mice with
some experiments performed in parallel with CD-1 mice, or in CD-1 mice alone. The first
study discussed also examined estrogen receptors in areas involved in sexual behavior.
Further work (Ismail, Garas, & Blaustein, 2011) replicated the effects of shipping
and LPS injection on sexual receptivity in CD-1 mice, an unrelated outbred strain, and
examined differences in estrogen receptor alpha (ERα). An injection of LPS at 6 weeks
significantly reduced sexual receptivity as compared to saline injected controls; an
injection of LPS at 8 weeks only reduced sexual receptivity in the fifth test session.
Shipping mice at ages 6 or 8 weeks decreased sexual receptivity relative to those shipped
at 3, 4, and 10 weeks in most test sessions. Finally, the effects of shipping on ERα were
examined in mice shipped at 4 or 6 weeks and euthanized one week after their second
sexual behavior test. Animals shipped had 6 weeks showed significantly fewer ERα –
stained cells in the arcuate nucleus, medial preoptic area, and ventromedial nucleus of the
hypothalamus, but not in the anteroventral periventricular nucleus. These experiments
replicated previous findings from C57Bl/6 mice, of the effects peripubertal stressor on
sexual receptivity, in CD-1 mice and established a vulnerable peripubertal period of 6
weeks of age for both shipping stress and LPS injection in CD-1 mice. Additionally, this
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paper demonstrates for the first time a difference in estrogen receptors in the brains of
peripubertally stressed animals.
Another paper expanding on the initial findings, (Olesen, Ismail, Merchasin, &
Blaustein, 2011), examined the effects of an injection of LPS on anxiety-like behaviors
under several conditions. In all three experiments both LPS and saline control animals
were split into two groups: animals either received an injection of estradiol benzoate
followed by progesterone or vehicle alone. The first experiment used only C57Bl/6 mice
injected at 6 weeks, while the second and third studies used C57Bl/6 and CD-1 mice
respectively injected at both 6 and 8 weeks. Although the results of the individual
behavioral tests (light/dark box, elevated plus maze, and marble burying task) vary,
together they show general trends for an effect of LPS injection, hormone, and age. In
almost all cases, saline treated mice that received estradiol exhibited lower anxiety-like
behavior than those administered oil, regardless of age of saline treatment. Similarly,
mice treated with LPS at 8 weeks that received estradiol showed decreased anxiety-like
behavior compared to those that received vehicle alone. Importantly, mice that received
LPS at 6 weeks had increases, or no change, in anxiety-like behavior when administered
estradiol rather than oil depending on the strain and task. In two tests, mice treated with
LPS at six weeks and oil showed decreased anxiety-like behaviors, compared to those
that received saline and oil. In conclusion, this paper demonstrated an effect of a
peripubertal injection of LPS on anxiety-like behavior in two unrelated strains of mice.
A peripubertal injection of LPS alters response to estradiol and progesterone with the
mice showing no change or an increase in anxiety-like behaviors compared to oil
controls.
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A paper examining memory, including tests of object recognition, object
placement recognition, social discrimination, and social recognition revealed further
effects of peripubertal stress (Ismail & Blaustein, 2013). CD-1 female mice were injected
at either 6 or 10 weeks of age with saline or LPS and implanted with Silastic© capsules
containing either estradiol in sesame oil or sesame oil alone at the time of ovariectomy. In
the tests for object recognition, object placement recognition, and social discrimination,
estradiol improved performance in mice treated with saline, at either age, and the mice
treated with LPS at 10 weeks. However, mice injected with LPS at 6 weeks had no
improvement on memory with estradiol. There were no differences between any groups
in a test of general locomotion, indicating that the differences in investigatory behaviors
were not due to differences in locomotion. Results on the social recognition task were
inconclusive. Therefore, this work provides evidence that a peripubertal injection of LPS
eliminates the positive effects of estradiol on cognitive tasks.
The most recently published paper, (Ismail, Kumlin, & Blaustein, 2013), focused
on depression-like behaviors and was conducted in both C57Bl/6 and CD-1 mice. For
both strains, there were two age groups of animals, one injected in the sensitive
peripubertal period (6 weeks of age) and one at a later period (8 weeks for C57Bl/6 and
10 weeks for CD-1). At ovariectomy half of the animals received a capsule containing
estradiol in sesame oil, the other half received capsules containing only oil. The results of
the tests were similar between strains. In both the forced swim test and tail suspension
test, the saline treated animals improve and show less depression-like behavior when
administered exogenous estradiol compared to those administered an oil vehicle alone,
regardless of treatment age. The same result is seen in animals treated with LPS at an
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older age. In the animals injected with LPS at 6 weeks, estradiol increased depressionlike behavior compared to oil. Neither strain displayed any differences in sucrose
preference. Unlike the forced swim and tail suspension test, this task is associated with
anhedonia rather than behavioral despair. As the authors point out, the role of estradiol in
the anhedonia in unknown. Thus, the lack of response may indicate either lack of a role
for estradiol in anhedonia. Further, the results may have been due to depleted estradiol
levels at the time of test administration, rather than indicating a lack of difference in
depression-like behavior. The differences in performance in the forced swim test or tail
suspension test are not due to changes in general locomotion as there were no differences
within either strain in locomotor activity. A subsequent unpublished analysis of the CD-1
data shows that in animals treated with vehicle only, those exposed to LPS performed
significantly better than saline controls in both tests (Holder, unpublished). In summary,
this paper demonstrates that in both C57Bl/6 and CD-1 mice a peripubertal injection of
LPS results in an increase in depression-like behavior rather than a decrease following
administration of estradiol.
Microglial activation
Recent work in the laboratory has begun to address the role of neuroinflammation
in effecting the changes observed in estrogen receptors and behaviors. This work,
(Holder, 2014), is focused on the role of microglial activation following the peripubertal
stressor. Preliminary results show differences in microglial activation in several brain
areas between animals subjected to either an injection of saline or LPS, or shipping, at
either 6 or 8 weeks of age. These findings indicate that in the arcuate nucleus and
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ventromedial hypothalamus, which play a role in feeding and sexual behaviors, LPS
exposure increases microglial activation more in 6 week mice than 8 week.
Summary
Together this body of work demonstrates the specificity of a period around
puberty in which certain stressors can elicit long-term changes in estradiol-influenced
behaviors. The existence of a sensitive peripubertal period has been demonstrated in two
unrelated strains of mice. While the effects were first established using shipping as a
stressor, the multi-faceted, variable nature of the stressor led to attempts to find a more
reliable stressor. Injection of LPS during the peripubertal period had similar effects on the
response to hormones in tests of sexual, anxiety-like, and depression-like behavior. The
effects of estradiol on depression- and anxiety-like behaviors appear to be paradoxical in
peripubertally stressed animals, insofar as these animals showed increased rather than
decreased depression- and anxiety-like behaviors. Additionally, an LPS injection appears
to alter some of these same behaviors in the absence of estradiol when compared with
saline treated controls. Exposure to a peripubertal injection of LPS also eliminates the
positive effects of estradiol on memory as demonstrated by hippocampal cognitive tasks.
A decrease in estrogen receptor alpha expression in areas of the brain associated with
sexual behavior points to a potential mechanism by which response to estradiol may be
altered. Finally, current work has begun to show changes in neuroinflammation following
the stressors at different ages, demonstrating a possible difference in early response to the
stressors.
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Obesity: connections with puberty, depression, estrogens, and inflammation
Introduction
In addition to the behaviors previously examined in the Blaustein laboratory,
estradiol regulates body weight (Brown & Clegg, 2010; Wade, Gray, & Bartness, 1985).
While some of the previous studies touched on short-term effects on body weight, no
systemic long-term study of the effects of a peripubertal stressor on body weight,
particularly without interruption by ovariectomy, have been undertaken. This area is a
potential avenue both for exploration of the effects on body weight but also for the
potential effects of increased adipose tissue on estrogen-influenced behaviors. Studies
from both human and rodent literature have pointed to interrelations between
inflammation, obesity, puberty, and depression with a complex relationship between
obesity and estrogens.
Some of these links are explored in the human literature, and some in rodent
models. While care must be taken not to try to directly relate results from one species to
another, female mice are a relevant model group for puberty in girls as will be discussed.
This section will first discuss connections between puberty, obesity, depression, and
estrogens in the human literature, and then will review other connections between these
factors, as well as inflammation, in mice. The section will conclude with a discussion of
the similarities and differences in female puberty in humans and mice.
Selected findings from human literature
For women, the average age of onset for mental disorders, including depression
and anxiety, falls during adolescence (Hayward & Sanborn, 2002). Puberty, timing of
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onset of puberty, and stress during puberty in girls have all been implicated in the
development of depression, vulnerability to later life stress, weight gain, and insulin
sensitivity (Ellis & Garber, 2000; Ge, Conger, & Elder, 1996; McCabe, Ricciardelli, &
Finemore, 2002; Patton et al., 1996). Women with severe mental illnesses are more likely
to be obese (Daumit et al., 2003), and recent work indicates that obesity is predictive of
depression (Luppino et al., 2010). A recent longitudinal study suggests that it is the
metabolic dysregulations that often occur in obesity, rather than obesity itself, that
increase the risk for developing depression (Hamer, Batty, & Kivimaki, 2012).
The relationship between obesity and depression is complex and reciprocal. While
obesity increases the risk for depression over time, depression also predicts the
development of obesity (M. S. Faith et al., 2011; Luppino et al., 2010). This is
particularly relevant in adolescent girls where the onset of depression in early
adolescence predicts the development of obesity in later adolescence, and development of
obesity during adolescence predicts depression in adulthood (Marmorstein, Iacono, &
Legrand, 2014). Specifically, increased visceral adipose tissue is associated with
depression in both men and women (Rivenes, Harvey, & Mykletun, 2009).
Just as obesity and depression are interlinked, the associations between obesity,
metabolic symptoms, reproductive difficulties, and estrogens are intertwined. Visceral fat
is also associated with insulin resistance, inflammation, and anovulation (Androulakis et
al., 2014; Melka et al., 2013). Not only is adipose tissue in adulthood associated with
metabolic phenotypes, but the timing of pubertal onset and observed changes in body
weight during puberty are predictive of obesity and metabolic syndrome in adulthood
(Ferreira, Twisk, van Mechelen, Kemper, & Stehouwer, 2005; Lawlor, 2005; McGill et
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al., 2000). Adipose tissue synthesizes testosterone in obese women without underlying
metabolic syndrome (Quinkler, 2004) and has been implicated as a source of testosterone
in women with polycystic ovary syndrome (Fassnacht et al., 2003). Complicating the
matter further, adipose tissue, specifically the stromal cells, is known to have high
aromatase activity and to produce estrogens, particularly estrone (Cleland, Mendelson, &
Simpson, 1983; Simpson, Merrill, Hollub, Graham-Lorence, & Mendelson, 1989).
Selected findings from rodent literature
Rodent models allow investigation into processes that researchers are unable to
address directly in humans due to time scale, practical, or ethical considerations. Most of
the information below comes from work in mice, but for clarity the studies performed in
rats or hamsters are noted as such. These studies show links between puberty, obesity,
estradiol, and inflammation; these relationships are frequently complex and like the
relationship between such elements in humans are far from fully understood. A few of
these relationships are discussed here.
The relationship between obesity, estradiol, inflammation, and puberty is tangled.
Removal of endogenous estradiol via ovariectomy increases adipose tissue, while
estradiol replacement following ovariectomy decreases adipose tissue in both rats (Wade
et al., 1985) and humans (Keith et al., 2006). Similarly, ERα knock out mice show
increased adipose tissue (Heine, Taylor, Iwamoto, Lubahn, & Cooke, 2000). Of particular
relevance to the work outlined below, lower than usual levels of estrogens during early
development can also lead to obesity during puberty as evidenced that the offspring of
dams fed low phytoestrogen feed during pregnancy develop obesity at puberty, indicating

11

that alterations in levels of estrogens during development can lead to enduring effects
during puberty and adulthood (Grün & Blumberg, 2009; Ruhlen et al., 2007).
Obesity is commonly referenced as an inflammatory disease (Kennedy, Martinez,
Chuang, LaPoint, & McIntosh, 2008). While numerous factors have been implicated, the
inflammatory response and obesity are linked at least partially by the mediation of tolllike receptor 4 (Tlr4), a gene involved in innate immunity (Milanski et al., 2009; Saberi et
al., 2009). A loss of function mutation in Tlr4 has been shown to prevent obesity in mice
fed a high fat diet that would normally induce obesity (Tsukumo et al., 2007). Male mice
exposed to a prenatal stressor show increased body weight in adulthood as well as
increased expression of Tlr4 as compared to unstressed males, or females regardless of
prenatal stress, suggesting that early life stressors can affect both body weight and the
expression of Tlr4 in adulthood (Bolton et al., 2013; Bolton et al., 2012). Microglia also
increase in number in the hypothalamus in mice exposed to dim light at night, although
the specific mechanisms are still unclear (Fonken, Lieberman, Weil, & Nelson, 2013).
This increase can be exacerbated by a high fat diet (Fonken, Lieberman, et al., 2013).
Additionally, hamsters exposed to dim light at night exhibit a heightened
neuroinflammatory response to an injection of LPS (Fonken, Weil, & Nelson, 2013). In
male mice, the exposure to dim light at night has also been shown to lead to obesity
(Fonken, Aubrecht, Melendez-Fernandez, Weil, & Nelson, 2013; Fonken et al., 2010)
and depression-like behaviors (Fonken & Nelson, 2013); female hamsters also show
depression-like behaviors following exposure to dim light at night (Bedrosian, Weil, &
Nelson, 2012).
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Puberty
Puberty is an important developmental stage in which many physiological and
behavioral changes occur and have lasting effects on both physiology and behavior later
in life (Forbes & Dahl, 2010; Marshall & Tanner, 1969). Key among these changes are
altered levels of hormone production, altered sensitivity to hormones, and remodeling of
the brain, due in part to steroid hormones (Schulz, Molenda-Figueira, & Sisk, 2009). In
girls, puberty is an extended period beginning with the onset of breast development and
ending with the first menses and takes approximately two to three years (Sizonenko,
1989; Tanner, 1962). In female mice, puberty begins with vaginal opening and ends with
regular estrous cycle and reproductive competence; these events can be separated by
several weeks (Vandenbergh, 1967, 1969). While several weeks may seem short in
duration, in an animal that has a lifespan of less than two years (for C57Bl/6 (Russell,
1966)), this constitutes a prolonged period. Due to the similarly prolonged pubertal
period, female mice are a relevant model for puberty in human girls.
Hypothesis for role of obesity in mediating estrogen-dependent processes following a
peripubertal stressor
In light of the possibility of an increase in body weight, a new hypothesis emerges
for the mechanism by which peripubertal stressors lead to the changes enumerated above.
The overarching hypothesis is that peripubertal stress induces a metabolic syndrome and
obesity, which in turn alters the hormonal environment, and leads to impaired response to
estradiol. Because the human literature examines women and girls with ovaries, this
hypothesis is proposed for intact females, although the enduring effects after ovariectomy
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and with exogenous hormone administration are addressed as well. The following
hypothesis is also illustrated in Figure 1.

Peripubertal Stressor

Inflammation
Δ Behavior & Metabolism
↑Weight Gain & Adiposity
↑Testosterone + ↑Aromatase

Unknown
Mechanism

↑Circulating Estrogens
↑Central Estrogens
↓Estrogen Receptors

Proposed Mechanism
Previously Proposed Mechanism

Δ Response to Estradiol
in Estradiol mediated behaviors

Figure 1. Hypothesis for obesity as a mediator of estrogen-dependent processes following
peripubertal stress.
It is hypothesized that a peripubertal stressor leads to inflammation in the brain.
This inflammation leads to changes in behavior and metabolism. These changes in turn
lead to increased weight gain and adiposity. The increased adipose tissue produces
increased plasma levels of testosterone. Increased adiposity also leads to increased
aromatase activity. This increased aromatase activity results in increased peripheral
circulating estrogens. Increased levels of estrogens in the periphery lead to increased
levels of estrogens in the brain. These increased central levels of estrogens result in longterm changes in the numbers, activity, and/or sensitivity of estrogen receptors in the
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brain. The changes in receptors may be limited to certain receptor types or to specific
regions. Finally, following ovariectomy, response to exogenous estradiol administration
is altered due to the changes in receptors as well as enduring endogenous estrogen
production by adipose tissue.
Overview of the following chapters
The hypothesis proposed above presents several unanswered questions and multiple
avenues for investigation. Because other work already focuses on the links between
peripubertal stressors and inflammation, the remaining sections here will address only the
following areas.
1) Is there an increase in weight gain and body weight following peripubertal
stressor?
2) What is the proximate cause of such weight gain?
3) Is obesity a mediator of estrogen dependent processes following pubertal stress
and does it work through the proposed mechanism?
The first question will be addressed in Chapter 2, which will examine data collected
during several studies each with other aims. The chapter will then propose a study to test
the question directly while addressing limitations for analyzing weight data raised by the
other studies from which data was collected. The second question will be addressed in
Chapter 3 where a primary and alternative hypothesis will each be presented and
followed by proposed studies to address the main points of the hypotheses. The third
point will be addressed in Chapter 4 where the questions from the hypothesis above will
be reviewed, and a study proposed to examine the effects of adiposity on several factors.
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While each of these chapters builds on expected results from the previous chapters, each
chapter will also briefly discuss possible alternative future directions.
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CHAPTER 2
WEIGHT GAIN INCREASE FOLLOWING EXPOSURE TO PERIPUBERTAL
STRESSOR
Introduction
Three experiments with different aims gathered weight data as part of the
experimental design, mainly to monitor animal health. Several members of the Blaustein
lab conducted these studies. The weight data from each of these three studies were
analyzed to determine if there is an effect of peripubertal stress on body weight in
adulthood. Because different experimental paradigms were used in each study, groups
cannot be compared across studies nor combined for greater statistical power. However,
the results of each study when examined side by side can provide insight into body
weight change with age following different peripubertal stressors in two disparate strains
of mice. Statistical analyses were conducted using HLM software to conduct hierarchical
linear regressions. Hierarchical modeling was chosen to analyze the data for several
reasons, most importantly because the data vary across both discrete (treatment) and
continuous (age) predictors.
Effect of mouse strain
As each of these experiments had a discrete aim, they each used the strain of
mouse most appropriate for the questions being asked. The first and third experiment
used CD-1 mice, which are outbred and are expected to show variability between
animals. The second experiment used C57Bl/6 inbred mice, which are expected to show
less individual variability, as they are genetically identical. CD-1 mice are larger than
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C57Bl6 mice at all age points studied and have other known differences as well,
including differences in sensitivity to estradiol (Spearow, 1999). Because two different
strains of mice were used across these three experiments, the results of the weight
analyses may yield information about other differences in the response to peripubertal
stress between strains or support previous demonstrations that strains are affected
similarly.
Effect of type of peripubertal stressor
The three experiments also use two different types of peripubertal stressors, as
well as two types of controls (Table 1). While the first and third experiment both use an
LPS injection as a stressor, and each include a saline injection control, the first
experiment also contains an non manipulated control group, which received no injection.
The second experiment also contains an LPS injected group, with a saline control group,
but also includes a group of mice, with the same birthdate, that were not injected but were
instead shipped to the research facility on the same day as injections were administered to
the other groups. The inclusion of two different stress types, as well as a non-injected
control, may allow conclusions about the similarity in effect of the different stressors and
support the use of a saline injection as an adequate control for LPS injection.
Table 1
Stressor and Control Groups for Previous Experiments

Peripubertal
Stressors
Controls

Experiment 1

Experiment 2

Experiment 3

LPS injection

LPS injection
Shipping

LPS injection

Saline injection
Non-injected

Saline injection

Saline injection
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Experiment 1
Experimental aim
The aim of this study was to examine the effects on estrous cyclicity in animals
administered a peripubertal stressor, in order to better understand the effects of such a
stressor on the hormonal environment without an invasive measure of plasma estradiol.
Animals were weighed before and after the peripubertal stress as well as before and after
ovariectomy in adulthood.
Methods
Animal use was overseen by the Institutional Animal Care and Use Committee of
the University of Massachusetts Amherst. 25 female outbred CD1 mice were purchased
from Charles River Laboratories and arrived at 21 days of age (P21). Animals were
housed in a temperature controlled, reverse light (14:10 LD, lights off at 10am) colony
room. The animals were housed 4-‐‑5 to a cage lined with CareFRESH bedding, and were
provided with a Nestlet at cage change. Cages were covered with a microisolator lid. All
animals had ad libitum access to phytoestrogen-‐‑reduced mouse chow [Teklad 2014] and
water.
All animals were monitored for vaginal opening by visual inspection beginning
the day after arrival. Following vaginal opening, cells were collected by vaginal lavage
from each animal daily (omitting P77-P83) until ovariectomy.
On P42 animals received an intraperitoneal injection of either sterile saline (n = 8)
or 1.5 mg LPS/kg body weight (n = 9), LPS was dissolved in sterile saline at a
concentration of 0.1mg/ml. Sickness behavior was monitored at 30 minutes, 4, 24, and 48
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hours and was scored by assessing ptosis, piloerection, huddling, and lethargy (after
(Ismail et al., 2011)). Body weight was also recorded. An additional group of eight
animals received no injection.
Animals were weighed in a 2l glass beaker on an Ohaus animal scale. At P113 all
animals were weighed prior to ovariectomy. Animal weights were tracked for several
days post surgery to check that animals stabilized and regained the weight lost during and
immediately following surgery.
Weights from six days between P28 and P115 were analyzed by hierarchical
regression to determine if there is a difference in body weight over time between the LPS,
saline, and not injected groups.
Results
Regression analysis shows a significant difference between the LPS and saline
treated groups (p<0.05) and between the control (non-injected) and saline treated groups
(p<0.05). No significant difference was detected between the LPS and control groups
(p=0.90). Analysis did reveal a significant difference in intercept between the saline and
control groups (p<0.05); there were no significant difference in intercept between LPS
and saline (p=0.59), although there was a trend towards difference between LPS and noninjected controls (p=0.06). The analysis did detect a significant amount of variance in
body weight that could not be explained by treatment effect at each age (p<0.05). Mean
body weights for each group at each age analyzed and linear trend are shown in Figure 2.
As adults, LPS and control animals weighed significantly (pLPS-Saline<0.05, pControlSaline<0.05)

more than saline treated animals as exemplified at by the mean body weights
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at P113 which were 32.1g for the LPS treated animals, 27.6g for the saline treated
animals, and 33.1g for the animals that did not receive an injection.
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Figure 2. Mean body weights for Experiment 1 for each treatment group at each age
analyzed with associated linear trend lines. Error bars represent standard error of the
means.
Discussion
There is a difference in body weight gain between LPS and saline treated mice
with LPS treated mice having a greater increase in weight than saline treated animals.
While this increase was hypothesized, the difference in increase in body weight of the
control group as compared to the saline treated was not. Indeed the similarity in body
weight increase between the LPS and control groups is problematic. Rather than
suggesting that peripubertal LPS treatment increased weight gain, these data indicate that
the saline treated control mice have a slowed or decreased weight gain. Additionally, it is
possible that the result of any injection during this sensitive period is more complicated
than previously thought. Specifically, it is possible that any injection during this period
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causes decreased weight gain compared to non-injected controls. However, the difference
in intercept, that is to say the difference in the body weights on the first day weights were
recorded, suggests that there may have been a difference in body weights between the
injected groups and the non-injected control group prior to administration of saline or
LPS.
The unexplained variance in the model is most likely due to the small sample
groups. These small sample groups and the lack of data points between the peripubertal
period and adulthood, make this analysis less valuable than it could be.
It should be noted here that this experiment was carried out under housing
conditions that were new to the laboratory at the time, namely the inclusion of a static
microisolator lid covering the cage. This practice was abandoned by the laboratory
following adverse outcomes for animals housed under these conditions not previously
seen in the lab. Moreover, the use of static microisolator lids has been demonstrated to
increase heat, humidity, ammonia, and carbon dioxide levels inside such cages (Gonder
& Laber, 2007). The use of these cages may have had detrimental effects on health and or
feeding in all animals that received injections causing decreased weight gain over time,
which may have been masked in LPS treated animals by the increased weight gain caused
by the LPS treatment.
In summary the results here do not support the hypothesis and cannot be
considered conclusive, as the two control groups (saline and non-injected) were
significantly different from each other. The observation, that the control group more
closely resembled the LPS group than saline group, cannot be explained.
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Experiment 2
Experimental aim
The aim of this study was to replicate previous findings demonstrating decreased
sensitivity to estradiol as demonstrated by decreased lordosis quotient in adulthood
following a peripubertal stressor. The replication study was performed following several
large-scale disruptions to the laboratory including an outbreak of murine parvovirus and
construction surrounding the building, which resulted in sound and vibrations thought to
disrupt mouse reproductive behavior (R. Faith & Miller, 2007; Rasmussen, Glickman,
Norinsky, Quimby, & Tolwani, 2009; Turner, Bauer, & Rybak, 2007). Several previous
replications were unsuccessful; although the reasons for this are unclear, the introduction
of new housing conditions is thought to have played a role. This study was performed
with the strain of mice used in earlier experiments. It also used both shipping during the
peripubertal period and injection of LPS. Animals were weighed throughout the
experiment in order to monitor animal health.
Methods
Twenty-four female inbred C57Bl/6 mice were purchased from Charles River
Laboratories; of these, 16 animals arrived at P22 and the remaining 8 arrived at P36.
Animals were housed with the same colony room, food, and water conditions as
described in the first study. The animals were housed 4 to a cage lined with sanichips,
and were provided with a Nestlet at cage change.
On P36 the animals that arrived at P22 received either a saline injection (n = 8) or
an injection of LPS (n = 8), as previously described. The animals that arrived at P36
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received no injection (n = 8). Sickness behavior and body weight were also recorded as
described in the first study.
Animals were weighed as previously described, at 8-9 am (lights out at 10am)
every 4-8 days. At P85, all animals were weighed prior to ovariectomy. Animal weights
were tracked for seven days post surgery to check that animals stabilized and regained the
weight lost during and immediately following surgery.
Beginning at P93 animals were injected and tested for sexual behavior weekly, for
five weeks. Animals were injected weekly with 2µg estradiol benzoate in 0.1mL sesame
oil subcutaneously followed 48 hours later with a subcutaneous injection of 100µg
progesterone in 0.1mL sesame oil. Animals were tested for lordosis response six hours
after progesterone injection.
Body weights from 13 separate days, beginning with P48 and ending with P123,
were analyzed by hierarchical regression to determine if there is a difference in body
weight over time between the LPS, saline, and peripubertally shipped groups.
Results
Regression analysis shows a significant difference between the shipped
(peripubertally shipped) and saline treated groups (p<0.05) and between the shipped and
LPS treated groups (p<0.05). No significant difference was detected between the LPS and
saline (p=0.997). Analysis did not reveal a significant difference in intercept between any
groups (pLPS-Shipping=0.48, pLPS-Saline=0.67, pSaline-Shipping=0.78). Mean body weights for
each group at the ages analyzed and linear trend lines can be seen in Figure 3. At P123,
the final weight measured, shipped animals weighed significantly more than saline
(p<0.05) and LPS (p<0.05) treated animals where the mean body weights were 23.6g for
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the LPS treated animals, 23.9g for the saline treated animals, and 25.9g for the
peripubertally shipped animals.
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Figure 3. Mean body weights for Experiment 2 for each treatment group at each age
analyzed with associated linear trend lines. Error bars represent standard error of the
means.
Discussion
As expected shipped animals had an increased body weight gain contrasted with
the saline treated animals. No difference was observed in weight gain between saline and
LPS treated groups; in fact, the similarity between the slopes of the linear regressions of
the two groups is striking (see Figure 3). These results clearly demonstrate the effects of
shipping at P36 rather than P22 on body weight, but it is less clear that it is simply a
peripubertal stressor that produces these results. Indeed, as LPS failed to produce a
difference in body weight, it is clear that either the two peripubertal stressors are not
equal in their ability to produce weight gain, acting as they presumably do through
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slightly different mechanisms or combinations of mechanisms, or that the LPS did not act
as a peripubertal stressor.
Indeed, although the LPS animals lost more weight following injection
(Appendix, Figure A1), they did not show levels of sickness behavior comparable to
previous studies (Appendix, Figure A2). Additionally, the results of the sexual behavior
testing showed no difference in lordosis quotient between any of the groups, although all
groups displayed abnormally low lordosis quotients with high variability (Appendix,
Figure A3). These results suggest that the LPS failed to make the animals as sick as
expected, and hence the injection failed to elicit the previously observed decrease in
sexual receptivity. In light of this, it is not surprising that the LPS treated animals failed
to show an increase in weight gain as compared to the saline controls. It is believed that
the method of preparing the LPS solution used for this study was unreliable and that the
dosage may have been far lower than intended. In this study, the LPS was prepared in an
extremely small volume by an inexperienced laboratory member. It is believed that the
low mass of LPS used, static electricity, and inexperience led to the loss of a substantial
portion of the LPS before saline was added.
It is interesting to note that although the animals that were shipped during the
peripubertal period did not show the expected decrease in lordosis quotient, they did
show increased weight gain. It is likely that the conditions in the laboratory were still not
sufficiently similar to the conditions under which the previous results (decreased lordosis
quotient in peripubertally stressed mice) were observed. The weight gain may either be
very robust, persisting even where other effects do not, or may be due to some other
element of the peripubertal stressor.
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In conclusion, together these results demonstrate that shipping during the
peripubertal period results in higher weight gain in C57Bl/6 mice compared to mice
shipped prior to puberty even in the absence of other previously observed outcomes. The
ability of an LPS injection to result in increased weight gain compared to saline controls
could ultimately not be conclusively proved or disproved as the animals failed to become
as sick as expected following the injection.
Experiment 3
Experimental aim
This study was conducted to replicate previous findings showing that exposure to
an LPS injection during the peripubertal period resulted in altered expression of
depression-like behavior in the presence and absence of estradiol. Additionally, this study
aimed to examine microglial expression, as a marker of inflammation, in areas of the
brain involved in depression-like behavior. In this study, animals were implanted with
capsules containing either estradiol in oil or the oil vehicle alone at ovariectomy;
therefore the examination of body weights was conducted beginning at ovariectomy at
which time the animals become four distinct groups. In this experiment animals were
weighed every four days.
Methods
Thirty-two female outbred CD-1 mice were purchased from Charles River
Laboratories and arrived at P21. Animals were housed with the same colony room, food,
and water conditions used in the previous two studies. The animals were housed 4 to a
cage lined with sanichips and were provided with a Nestlet at cage change. Prior to
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ovariectomy the animals were housed in cages topped with a microisolator lid in a
ventilated cage rack; following ovariectomy, animals were housed in shoebox cages with
a wire mesh lid on a wire rack.
On P42 animals received an injection of either saline (n =16) or LPS (n = 16), as
previously described. Sickness behavior and body weight were recorded and assessed as
in the previous two studies.
Animals were weighed as previously described at 8:45-9:45 am (lights out at
10am) every 4 days. At P78 all animals were weighed prior to ovariectomy. All animals
were ovariectomized and implanted with a Silastic© capsule (length: 2.5cm, internal
diameter: 1.57mm, external diameter: 3.18mm) containing either 50µg E2 in 25µl sesame
oil or 25µl sesame oil vehicle alone. Animal weights were tracked for seven days post
surgery to check that animals stabilized and regained the weight lost during and
immediately following surgery.
One week following ovariectomy animals were tested in an open field test to
assess differences in general locomotor behavior. Two and three weeks following
ovariectomy the animals were then subjected to the tail suspension test and forced swim
test to examine depression-like behavior.
Weights from eight days, beginning with P78 and ending with P106, were
analyzed by hierarchical regression to determine if there is a difference in body weight
over time between the groups, and specifically whether there is an interaction between
treatment (LPS or saline) and hormone treatment (estradiol or vehicle).
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Results
Regression analysis shows a significant main of effect of hormone (p<0.05) but
not of treatment (p=0.16). There is no significant interaction between treatment and
hormone (p=0.25). Analysis did not find a significant difference in intercept for any
terms (pTreatment=0.95, pHormone=0.23, pInteraction=0.39). The analysis did detect a significant
amount of variance in body weight that could not be explained by treatment, hormone, or
interaction at each age (p<0.05). Mean body weights for each group at the ages analyzed
and linear trend lines can examined in Figure 4. At the final weight measured on P106,
there was no significant difference (p=0.54) in body weight between LPS and saline
treated animals (when collapsed across hormone capsule type), but animals with an oil
vehicle capsule weighed significantly (p<0.05) more than those with an estradiolcontaining capsule (when collapsed across treatment).
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Figure 4. Mean body weights for Experiment 3 for each treatment group at each age
analyzed with associated linear trend lines. Error bars represent standard error of the
means.
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Discussion
Animals implanted with an oil capsule had increased weight gain compared to
those with estradiol capsules as predicted. The lack of increased weight gain in animals
treated with LPS was unexpected, as was the lack of interaction between LPS treatment
and capsule. A possibility for the lack of effect is that the age at which the animals were
ovariectomized may have impacted weight gain. The animals in this study were
ovariectomized five weeks earlier than the animals in the first study.
In conclusion these data do not support the hypothesis, nor do they replicate the
results of the first study showing that an LPS injection during the peripubertal period
results in increased weight gain and higher body weight in adulthood in CD-1 mice.
Conclusions
Taken singly these studies do not provide strong evidence for the universality of
increased weight gain following a peripubertal stressor. However, together these results
begin to paint a clearer picture of the impact of peripubertal stressors on body weight.
While none of the studies individually can answer the question of whether different types
of peripubertal stressors cause increased weight gain in genetically diverse strains of
mice, the individual results tell us the following:
1) LPS injection may increase weight gain or may mask, or counteract, decreased
weight gain following any injection during the peripubertal period in CD-1 mice
2) Shipping during the peripubertal period results in increased weight gain as
compared to saline treated mice shipped prior to the period in C57Bl/6
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3) LPS injection during the peripubertal period may result in increased weight gain
as compared to saline injection in CD-1 mice but may be confounded by age of
ovariectomy
Together these studies indicate that, although both LPS and shipping may result in
increased weight gain as compared to saline controls, and that this weight gain might be
seen in unrelated strains of mice, many details still need to be clarified.
Limitations and unanswered questions
Despite the conclusions that begin to emerge from the previous three studies,
some of the initial questions remain unanswered due to limitations of each experiment. In
order to better understand how ultimately to answer these questions, the limitations must
be identified and addressed. They fit into three main areas: adequate controls for the
purposes of comparing weight gain, reproducibility between and within strains and
stressors, and the effects of timing of ovariectomy and administration of hormones.
First, because the second and third experiments lacked a non-injected control
group, the groups in each of these experiments cannot adequately be compared. In the
second study, the peripubertally shipped mice and mice shipped earlier in life should
have been compared with a group shipped earlier in life but not injected; without such
comparison it is unclear whether shipping truly increases weight gain. The results of the
second study could indeed show a decrease in weight gain in the saline injected group as
seen in the first study, with the peripubertally shipped mice showing normal weight gain.
However, without a group shipped prior to puberty and not injected, this is impossible to
determine. The third study also lacked a non-injected group and it is unclear how such a
group would have compared to the saline or LPS groups.
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Second, while there are LPS data from CD-1 mice and peripubertal shipping data
from C57Bl/6 mice, there is no indication that either strain responds to both of the two
different stressors in a similar manner in terms of weight gain, nor indeed that the two
strains show similar increases in weight gain to one another following the same stressor.
This point is key in the understanding of the effects of these stressors; regardless of other
experimental limitations, the lack of these data alone prohibits drawing conclusions on
the effect of peripubertal stress on weight gain.
Third, the increase in weight gain appears to begin in adulthood, rather than
immediately following the stressor (as seen in Figure 3); therefore, ovariectomy at this
age may alter results. The differences in study design make it difficult to draw
conclusions about the effects that ovariectomy, or differing hormonal treatments, may
have had on differences in weight gain between groups. In the first study the weight data
were only recorded for two days following the surgery, making examination of longerterm effects impossible. In the second study, weight data were available for five weeks
following ovariectomy, but animals were treated weekly with estradiol injections. It
should be noted that, in these animals, the difference in weight was significant prior to
ovariectomy. In the third study, weight data were available for four weeks following
ovariectomy but because animals received either constant levels of estradiol or no
estradiol, again it is difficult to piece apart the effects that the surgery itself might be
having on body weight longer term (following the recovery period) versus the effects of
treatment on body weight. These animals were ovariectomized five weeks earlier than the
CD-1 mice from the first study (one week earlier than the C57Bl/6 mice in the second
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study); it may be that the ovariectomy somehow interfered with an emerging difference
in weight gain.
Together, these differences in the three studies, as well as the limitations of the
individual studies, such as LPS failing to induce normal sickness in the second study,
combine to produce a very tenuous basis for conclusions. In order to conclude that
peripubertal stressors do indeed increase weight gain, and body weight in adulthood,
additional studies are necessary.
Proposed experiment to test alterations to weight gain following a peripubertal
stressor
Experimental basis
The final section of this chapter proposes a study, which should provide more
conclusive evidence regarding the effects of LPS and shipping on weight gain. This
section discusses how these experiments will overcome the limitations of the previous
experiments.
First, this study addresses the lack of comparability between strains and stressors
by including both stressors in a single experiment and then replicating the experiment in
the other strain. Because both strains will be exposed to both stressors, the universality of
the increased weight gain across strains should be evident despite the different body sizes
of the two strains. Similarly, in the event that the stressors affect the strains differently,
this should be evident both within and between the two experiments.
Second, these experiments address the lack of control group for the second and
third experiments by including a non-injected control group shipped at P21 which will
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serve both as a control for the animals injected with saline and LPS at P42, and as a
control for the animals shipped at P42. In order to establish that it is not simply that an
LPS injection at any age causes weight gain, the second part of the experiment tests an
additional cohort that will be injected with either LPS or saline at P63, an age which does
not cause enduring effects of LPS injections (Ismail et al., 2011; Laroche et al., 2009a).
The non-injected control will serve as a control group for these animals as well.
Third, the possible effects of ovariectomy are examined by including both
ovariectomized and unaltered subgroups in the third part of the study. All animals,
regardless of treatment, will be kept until P119. Examination of intact animals and
animals ovariectomized, but not receiving hormones, should help to determine whether
ovarian secretions influence the difference in weight gain. The mice will be
ovariectomized at the same age used in the third study and should help to determine
whether ovariectomy alters the change in weight gain.
Experimental design
This series of experiments is large and involves the use of large numbers of
animals; the breadth is necessitated by the myriad possible factors affecting weight gain
with age as enumerated above and by the necessity of performing the experiments in both
CD-1 and C57Bl/6 animals.
The following experiments will be performed first in CD-1 animals, and then
repeated entirely in C57Bl/6. The study is divided into three parts; the experimental
groups for each part of the study are shown in Table 2. The experimental procedure is
outlined below and is followed by a figure depicting the timelines for each part (Figure
5).
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Table 2
Experimental Groups for Parts 1, 2, and 3
Groups

Part 1

Part 2

Part 3

Non-injected control

Yes

Yes

Yes

LPS injection

P42

P42 & P63

P42

Saline injection

P42

P42 & P63

P42

Shipping stress

P42

–

–

Ovariectomized

–

–

Yes (½ each above)

4

5

6

Total groups

Part 1
Animals with the same birthdate will arrive at 3 weeks (P21) and 6 weeks (P42)
of age. Twenty-four animals will arrive at 3 weeks; eight animals will arrive at 6 weeks.
Animals will be housed with 3 conspecifics upon arrival. On P42 all animals will be
weighed; thereafter all animals will be weighed every four days for experimental body
weight data. Also on P42, at approximately 9 am, 16 of the animals that arrived at 3
weeks will be injected with either LPS (1.5 mg/kg) in sterile saline (n = 8) or saline
vehicle alone (n = 8). The remaining animals will not be injected. Sickness behavior
including lethargy, huddling, ptosis, and piloerection will be recorded at 30mins, 4, 24,
and 48hrs following injection. Body weight changes will be monitored daily for seven
days. These measures will be recorded for all animals regardless of treatment. Animals
will continue to be weighed every four days until P119 when the experiment will
conclude.

35

Part 2
Forty animals will arrive at 3 weeks (P21) and will be housed and weighed as
above. On P42 a subset of the animals will receive either an injection of LPS (n = 8) or
saline (n = 8) as previously described. Sickness behavior and body weight changes will
be recorded as described above. At 9 weeks of age (P63) a subset of the previously
untreated animals will be injected with either LPS (n = 8) or saline (n = 8) following the
same procedure as at P42. The remaining animals will remain as a non-injected control (n
= 8). Sickness behavior and body weights will be recorded as previously described for all
groups. Animals will continue to be weighed as previously described until the conclusion
of the experiment at P119.
Part 3
Forty-eight animals will arrive at 3 weeks (P21); the animals will be housed and
weighed as above. On P42 the animals being injected will receive either an injection of
LPS (n = 16) or saline (n = 16) as previously described. The remaining animals (n = 16)
will remain as the non-injected controls. Sickness behavior and body weight changes will
be recorded as described above. At 11 weeks of age half of each group will be
ovariectomized (n = 8, for each peripubertal treatment group). Body weights will be
recorded daily for one week to assess recovery. As in the previous parts, animals will
continue to be weighed every four days until day 119 when the experiment will conclude.
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Part 1

Animals Arrive (n=24) Animals Arrive (n=8)
LPS/saline injection - week 3 arrival animals (n=8/group)

Part 2

Animals Arrive (n=40)

Part 3

Animals Arrive (n=48)

LPS/saline injection
(n=8/group)

LPS/saline injection
(n=8/group)

LPS/saline injection (n=16/group)
Week

3

6

9

Ovariectomy (n=8/treatment group)
12

15

Tissue
Collection

Sickness behavior monitoring at 30 mins, 4hr, 24hr, and 48hr
Body weight recorded daily for 7 days
All animals weighed on P42, then every fourth day until P119

Figure 5. Experimental design for proposed study examining the effects of peripubertal
shipping stress, LPS injection, and ovariectomy on weight gain and body weight.
Limitations and future directions
While these experiments endeavor to address all of the limitations encountered
from the data analyzed from previous studies it cannot be fully comprehensive. Several of
the identified limitations to this experiment are discussed. First, this experiment does not
address the possibility that shipping at any age after P21 might cause increased weight
gain; this question is, however, tested in an experiment in Chapter 3. Second, in the event
that non-injected control animals more closely resemble LPS injected or shipped animals
in weight, with saline animals showing a decrease in weight gain, this experiment will be
inadequate to address whether it is specifically a saline injection that induces this gain or
whether LPS masks an injection effect as no sham injected group (a group receiving an
intraperitoneal needle stick but no injection) or group orally administered LPS is
included. Third, in relation to ovariectomy and hormone administration, this experiment
will not examine effects of exogenous estradiol on body weight gain, or address whether
the results of surgery alone might affect weight gain as no sham ovariectomy group is
included. However, both of these questions could provide the basis for future experiments
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especially depending on any differences in weight gain detected between peripubertally
stressed animals that are ovariectomized and those that are not.
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CHAPTER 3
PROXIMATE CAUSE OF INCREASED WEIGHT GAIN
Possible causes of increased weight gain
There are several possible mediators for increased weight gain: (i) behavioral
changes such as an increase in feeding and/or a decrease in locomotor activity; (ii) a
change in basal metabolic rate; and (iii) a change in the daily timing of feeding and
activity which results in a change in metabolism but not total food consumption or
activity. Mice exposed to dim light at night, a circadian disruption and stressor, show an
increase in depression-like behavior (Fonken & Nelson, 2013) and increased body weight
(Fonken, Aubrecht, et al., 2013; Fonken et al., 2010); in these animals, it has been
demonstrated that the increase in body weight was not due to a change in total
consumption or activity but instead to an alteration in the daily pattern of when the
animals feed and were active (Fonken et al., 2010). Stressors such as shipping and an
LPS injection are both thought to cause neuroinflammation; when administered in
conjunction LPS has been shown to increase the neuroinflammation seen following
circadian disruption (Fonken, Weil, et al., 2013). Because induction of
neuroinflammation is the commonality between circadian disruption, LPS, and shipping,
it is expected that both LPS and shipping will lead to increased weight gain through an
alteration of timing of feeding and activity and resultant changes in metabolic rate. The
experiments described in the following section attempt to disambiguate between the
possible causes of increased weight gain by examining feeding and locomotor behavior
as well as metabolic rate and body composition.
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Specifically, the behavioral parameters of feeding, general locomotion, and wheel
running will be examined using behavioral cages and analyzed for both total levels and
patterns of activity over 24 hours. Mice supplied with a running wheel will run
voluntarily. While general locomotor activity will reveal any differences in total
locomotion, wheel-running activity will provide a more robust measure for determining
differences in activity pattern over 24 hour periods (Verwey, Robinson, & Amir, 2013).
These tests will be run separately from other behavioral behaviors because wheel-running
behavior itself can induce other behavioral changes, and thus cannot be used as the sole
measure of activity (Novak, Burghardt, & Levine, 2012). Metabolic rate will be assessed
by daily energy expenditure as determined by gas exchange in a metabolic chamber, as
well as by body temperature. Animals with lowered metabolic rate show lowered core
body temperature (Pelleymounter et al., 1995), and these data will further support daily
energy expenditure data in determining if metabolism is altered. Body composition will
be examined by comparing fat, muscle, and bone mass calculated using live radiographic
imaging, and by further analysis of amount of white adipose versus metabolically active
brown adipose tissue. It is important to examine muscle, bone, and adipose mass to
differentiate increases in overall growth from increases in adiposity. Similarly, by
examining the proportion of white to brown adipose tissue it can be determined whether
alterations observed in metabolism are due to alterations in amounts of metabolically
active brown adipose tissue.
Expected outcomes
As discussed previously it is expected that the animals exposed to a peripubertal
stressor will show altered feeding and activity patterns over the day as compared to
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controls. The result of these altered behavior patterns is expected to be reflected in altered
metabolic rate as measured by decreased energy expenditure and body temperature. The
peripubertally stressed mice are also expected to have higher percentage of adipose tissue
than the control animals. They are also expected to have less brown adipose tissue
relative to white adipose tissue, although not a difference total brown adipose tissue.
Experimental design
The following experiments use C57Bl/6 mice and shipping as a peripubertal
stressor. Following the full experimental methods are additional methods to be used to
replicate the experiment using an injection of LPS during the peripubertal period as a
stressor, as it may be instructive to determine whether LPS and shipping affect weight
gain by the same proximate mechanisms. Figures illustrating the experimental timelines
for both the shipping stressor (Figure 6) and LPS injection (Figure 7) experiments follow
the descriptions. If the experiments described in Chapter 2 show differences in weight
gain between strains and stressors these experiments should be repeated with CD-1 mice
as necessary and the stressors chosen as appropriate to the strain being tested.
Metabolic cages
The following will examine behavior and metabolic rate by measuring feeding,
locomotion, and energy use directly using a metabolic cage. 24 female C57Bl/6 mice will
arrive at 3 and 6 weeks (n=12 per week). Animals will be housed with 3 conspecifics
upon arrival, and will be isolated at 12 weeks for 96 hours of testing in a metabolic cage.
This amount of time in the metabolic cages will be sufficient to collect accurate measures
of activity and daily energy expenditure (Speakman, 2013), while minimizing stress on
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the animals due to single housing. Feeding and drinking behavior will be monitored at
regular intervals. Locomotor activity will be measured by beam break. Daily energy
expenditure will be measured by calculating basal metabolic rate and respiratory
exchange rate from oxygen and carbon dioxide gas exchange (Speakman, 2013). In a
subset of 4 animals from each group, animals will be surgically implanted with
temperature probe in the abdomen at 9 weeks of age to measure core body temperature.
To eliminate inadvertently examining possible temperature changes due to exposure to
the behavioral test cages themselves, temperatures will be recorded for 96 hours before
and after the behavioral testing. Beginning at 6 weeks all animals will be weighed every
fourth day.
Behavioral cages
Activity patterns over the day will be further examined using behavioral cages
equipped with a running wheel. Animal numbers and protocol will mirror those given in
the previous experiment with the exception that instead of metabolic cages, animals will
be tested in a behavioral cage where only wheel running and feeding activity will be
recorded and analyzed. In order to ensure that animals will recognize the running wheel,
animals will be housed with an identical running wheel in their group housing conditions
upon arrival. Body temperatures and weights will also be recorded as in the previous
experiment.
Body composition
In order to establish that changes in body weight are due to increases in adipose
tissue rather than increases in muscle tissue or general growth, the body composition of
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all animals used the previous two experiments will be analyzed using a live radiographic
imaging system 4 days after behavioral testing. Percentage body fat, bone, and muscle
mass will be compared between all 4 groups. Additionally, distribution of white versus
brown adipose tissue will be analyzed.
Animals Arrive
(n=12)

Animals Arrive
(n=12)

Body Composition Testing
Tissue
Collection

*
Week

3

6

9

* Temperature Probe Implantation (n=4)

12
Body weights recorded every four days
beginning one day following week six

Behavioral Testing (96hrs)
Body Temperature Recording (288hrs)

Figure 6. Experimental design for proposed experiments examining the proximate causes
of increased weight gain following a peripubertal shipping stress.
Using LPS as a peripubertal stressor
24 female C57Bl/6 mice will arrive at 3 weeks of age. As in the shipping
experiments, animals will be housed with 3 conspecifics upon arrival. The animals will
receive an injection of LPS (1.5 mg/kg) or saline vehicle at 6 weeks of age. Sickness
behavior including weight change, lethargy, huddling, and piloerection will be recorded
at 4 time points. At 12 weeks the animals will be isolated for 96 hours of testing in a
metabolic cage. Feeding behavior, locomotor activity, metabolism, and body weight will
be tested by the same methods used in the shipping stress experiments with the exception
that all animals will be weighed every fourth day beginning the day after arrival at 3
weeks.
As in the shipping stress experiments, activity levels will be further examined
using behavioral cages equipped with a running wheel. Animal numbers and protocol
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will mirror that of the previous experiment with the exception that instead of metabolic
cages, animals will be tested in behavioral cages as in the second shipping experiment.
Finally, body composition of animals will be examined in the same manner as the
shipping stress animals.
Animals Arrive
(n=24)

LPS/Saline
Injection

Body Composition Testing
Tissue
Collection

*
Week

3

6

9

* Temperature Probe Implantation (n=8)

12
Body weights recorded every four days
beginning one day following arrival, and
for five days following Injection

Behavioral Testing (96hrs)
Sickness Behavior Monitoring (48hrs)
Body Temperature Recording (288hrs)

Figure 7. Experimental design for proposed experiments examining the proximate causes
of increased weight gain following a peripubertal injection of LPS.
Potential pitfalls and future directions
Although no difference is expected in total feeding or locomotor activity,
alterations in either of these behaviors would indicate these behavioral changes as the
mediators of weight gain instead of, or in addition to, metabolic or daily pattern changes.
Future work would then examine the underlying mechanisms promoting these changes in
addition to mechanisms underlying metabolic changes; such studies are discussed in the
following sections of this chapter. In the event that radiographic imaging is unavailable,
brown and white adipose fat pad weights will be compared following gross dissection of
the pads of each group of animals and carcass analysis of the remaining animals. It is also
recommended that, if carcass analysis is unnecessary, blood and brains be collected and
preserved for future analyses, such as those discussed in Chapter 4.
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Role of diet switch in increased weight gain
Findings indicating a change in total feeding or locomotor activity or in
metabolic, but not activity patterns, would necessitate further exploration of the structural
and hormonal underpinnings of the change in metabolism, or behavior, that directly cause
the differences in weight gain in adulthood. Particularly when examining the mice
shipped during the peripubertal period, one potential avenue for research concerns the
change in chow that the mice experience when they are transferred from the breeder to
the laboratory facility. While the animals experience a wide variety of changes (tap
water, air quality, housing conditions, cagemates) upon arrival at the laboratory, the
change in food is important to consider both in regards to long established and recent
findings. It has long been understood that a change in food can have impacts on both
body weight and reproduction, which can endure for several generations, and that
different strains of mice are differently sensitive to changes in food (Hoag & Dickie,
1966). Much recent work has focused on the interactions between the microbiome and
the body (McFall-Ngai et al., 2013), specifically on the microbiome and obesity
(Cotillard et al., 2013; Everard et al., 2013; Ley et al., 2005). Not only do the animals
experience a change in food when they arrive at the laboratory, but the chows are known
to vary in two potentially important elements.
The two chows used by the animal supplier (Purina 5L79, 5% fat chow) and used
by the Blaustein laboratory (Teklad 2014, phytoestrogen-reduced, 4% fat chow) differ in
both phytoestrogen and fat content. These differences could elicit changes either alone or
in conjunction with the stress of either shipping or an LPS injection during the sensitive
period. The switch of chow before the peripubertal period might occur at a time when the
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body can adapt to the changed nutrient or hormone content, while the animal may be less
plastic in its ability to adjust to a new food during the peripubertal period. These changes
in response may be due to classical physiological mechanisms or to alterations in the
microbiome.
A switch from a high fat to lower fat diet may cause a fundamental shift in
metabolism inducing a famine state in animals with subsequent weight gain and lower
metabolic rate. Alternatively, the lower fat diet may cause an increase in food
consumption and/or a decrease in either locomotor behavior or metabolic rate, which
could also lead to increased body weight. The lowered concentration and variability of
phytoestrogens present in the Blaustein laboratory food may also contribute,
independently or in interaction with the change in fat content, to changes in weight by
altering either behavior or metabolism. Estrogens have been previously demonstrated to
cause changes in body weight in rodents – sometimes positively, sometimes negatively
(Keith et al., 2006).
Alternatively, the change in feed may also point to a role for the microbiome in
regulation of estradiol. Recent work has shown a link between an animal’s hormone
secretion, microbiome, and hormonal and metabolic response (Markle et al., 2013). It
may not be the animal’s inherent inability to adjust to switching the chow but the
microbiome’s inability to adapt or change of gut flora, which induces a change in
metabolism and or behavior.
Examining effects of diet switch and shipping stress on body weight experimentally
In order to test the possible effect of change of diet on weight gain, the
experiment will include groups of mice bred in the laboratory on either on the Purina
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5L79, 5% fat chow or the Teklad 2014, phytoestrogen-reduced, 4% fat chow, and would
examine the effect of switching chows, the timing of switching chows, and the presence
or absence of an additional stressor at time of chow switch on body weight. A figure
(Figure 8) outlining the experimental design follows the description. Although outlined
only briefly here, future work should also explore possible differences and changes in the
microbiome on different chows, following switches in chows, and in response to
peripubertal stressors shown to elicit changes in body weight. Finally, this section closes
with a discussion of the implications of results of the following experiment and what
future experiments might be necessitated by certain results.
Experimental design
This study will use both female C57Bl/6 mice bred in the laboratory from dams
purchased from the supplier and mice bred by the supplier and shipped to the laboratory
at several ages. Animals bred in the laboratory will be raised on two different chows;
eight animals will be raised on the laboratory’s standard Teklad 2014, phytoestrogenreduced, 4% fat chow, another 32 animals will be raised on the standard chow used by
the supplier, Purina 5L79, 5% fat chow. At each of 3, 6, and 9 weeks of age, eight
animals will be switched from the Purina chow to the Teklad. The animals will be
weighed daily for a week following the change in chow, and then will be weighed every
four days for the rest of the study. The animals raised in the laboratory that remain on
their original chow will be weighed every four days beginning at week 3. 48 animals will
arrive from the supplier, 16 each at 3, 6, and 9 weeks of age; upon arrival half of each
group (eight animals) will be switched to Teklad chow, the other half will continue to
receive the chow they received at the breeding facility. All animals will be weighed
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every day for a week following arrival, then every four days for the duration of the study.
All animals will be aged to P106 (15 weeks+) when the experiment will terminate.
Animals bred by Supplier
Animals Arrive
Animals Arrive
Animals Arrive

Week

3

6

9

12

15

Tissue
Collection

Purina 5L79, 5% fat chow
Teklad 2014, phytoestrogen-reduced, 4% fat chow

Animals bred in Laboratory

Figure 8. Experimental design for proposed experiment examining the effects of chow, a
switch in chow, and shipping on weight gain, when chow switch and shipping occur
before, during, or after the sensitive peripubertal period.
Microbiome and other future directions
Pending the results of the previous experiment, the next logical step may be to
examine differences in the microbiomes of animals fed different chows, specifically those
that show difference in weight gain. As this laboratory does not have expertise in the
microbiome, a collaboration is suggested in which the flora of the different groups would
be profiled – if planned, it may be possible to collect from the mice from the previous
experiment at the conclusion of the study. Alternately, or perhaps additionally, a rescue
of mice showing increased weight gain might be attempted by fecal transplant from
animals showing normal weight gain in a future experiment, again, in collaboration with
a laboratory with experience in these techniques.

48

Unexpected results and further experiments
Because the following chapter builds on expected results from the studies outlined
here, namely that change in weight gain will be due either to the conjunction of switch in
chow and peripubertal stressor or peripubertal stressor alone, it is important to discuss the
other possible results. If the increase in weight gain is due the change in chow alone, then
the increased adipose tissue may still result in alterations of estrogens and estrogen
receptors. The experiments outlined in Chapter 4 could still be performed to establish
whether these mechanisms explain the other changes seen in animals exposed to
peripubertal stressors in the Blaustein laboratory. However, a more direct experiment to
test the fundamental basis of this hypothesis would be to repeat earlier experiments on
sexual receptivity, cognition, and depression-like behaviors using mice kept on one chow
for their entire lifespan. This repetition might also be performed if both switch in chow
and a peripubertal stressor result in increased weight gain. If on an unchanging chow, the
same results are seen in the behavioral tests as previously, the role of chow switch can be
abandoned as the alternation in response to estradiol. If, however, chow switch alone
results in increased weight gain, and behavioral tests repeat previous results with an
unchanging diet, the hypothesis established in Chapter 1 (that obesity mediates estrogendependent processes following a peripubertal stressor) should be rejected as behavior test
results would be independent of diet induced adiposity.
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CHAPTER 4
OBESITY AS A MEDIATOR OF ESTROGEN DEPENDENT PROCESSES
FOLLOWING PERIPUBERTAL STRESS
Introduction
The elements of the hypothesis to be discussed and tested in this chapter are those
that occur as a result of increased adipose tissue. Because the difference in body weights
occurred before ovariectomy in the two studies in which it was observed, all of the
following experiments will be performed in non-ovariectomized animals. These
experiments will address the portions of the hypothesis concerning the following.
1) Whether adiposity results in increased testosterone levels and aromatase activity
2) Whether adiposity results in increased levels of circulating estrogens
3) Whether adiposity results in increased central levels of estrogens and whether
these levels correlate with altered peripheral levels of estrogens
4) Whether adiposity results in changes in expression of estrogen receptors in the
brain
Experimental Overview
These experiments will address the questions above by examining differences in
obese and average weight animals. First, plasma testosterone levels will be examined and
aromatase activity will be examined by comparing aromatase activity in adipose tissue.
Second, estrogen levels will be examined by assaying plasma levels of estrone and
estradiol. These two estrogens have been chosen for analysis, as estrone is the primary
estrogen produced by adipose tissue (Cleland et al., 1983), and estradiol is the most
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active estrogen in reproductive aged females (Feder & Silver, 1974). Third, central
estrogen levels will be compared in the hippocampus and the hypothalamus areas using
homogenized tissue. The choice of these regions is due to the role of the hippocampus in
cognition and depression-like behaviors, and the role of areas of the hypothalamus in
feeding and sexual behavior. Finally, estrogen receptors in the brain will be examined by
comparing regulation of ERα, ERβ, and GPR30 by examining mRNAs specific to each
receptor type. Specifically, the hippocampus and medial basal hypothalamus will be
examined for their roles in the behaviors listed above; the amygdala will also be
examined.
The following experiments use one cohort of animals in order to reduce animal
numbers and duration of experiment. If the results are positive the experiments should be
repeated with a cohort of animals that experience a peripubertal stressor, in order to
confirm that adiposity induced by peripubertal stressor is working by the same
mechanisms.
Experimental design
32 female C57Bl/6 mice will arrive at 11 weeks of age. 16 of these animals will
be standard C57Bl/6 animals, reared on Purina 5TJS, 5% fat chow (“Western Diet”
control). The other 16 animals will be diet-induced obesity animals, animals that have
been induced to obesity by being reared on the high fat diet Purina 5TJN, 20% fat chow
(“Western Diet”). The animals will be allowed to recover from shipping for one week;
body weights will be recorded daily. Because diet induced obese animals can rapidly
begin to lose weight when placed on a standard chow (Parekh, Petro, Tiller, Feinglos, &
Surwit, 1998), animals will be fed the same chows as at the breeding facility. At 12
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weeks of age, animals will be deeply anesthetized with an injection of pentobarbital,
blood will be collected by cardiac puncture, and the animals will be decapitated. Brains
will be collected and preserved as described in sections below. Blood will be collected in
EDTA coated tubes and plasma separated via centrifugation. Plasma will be aliquoted
and stored at -80ºC. Abdominal fat pads will be removed, weighed, flash frozen, and
stored at -80ºC. Collected tissues will then be analyzed as described in the following
sections and in Figure 9.
Testosterone and aromatase
Plasma will be assayed for testosterone levels using a commercially available
ELISA kit.
Aromatase activity will be measured in adipose tissue. Tissue will be thawed,
homogenized and then aromatase assessed using either a commercially available ELISA
kit to measure concentration of aromatase or following the methods established by
Lephart & Simpson (Lephart & Simpson, 1991) to determine aromatase activity.
Peripheral estrogens
Plasma collected from the mice above will be assayed for both estrone and
estradiol using commercially available ELISA kits.
Central estrogens
Brains collected from half of each group will be rapidly microdissected and the
hippocampus and hypothalamus from each animal flash frozen and stored at -80ºC until
use. Brain areas will be thawed then homogenized and estrogens extracted using an ether
extraction followed by solid phase extraction as established by Chao (Chao, Schlinger, &
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Remage-Healey, 2011). Central levels of estrone and estradiol will be determined using
the same commercially available ELISA kits used in the above analysis.
Expression of estrogen receptors in areas key in estrogen-dependent behaviors
Brains collected from the remaining half of each group will be microdissected.
The amygdala, hippocampus, and medial basal hypothalamus will be dissected and
preserved in RNAlater®. Preserved sections will be incubated overnight at 2-8ºC, then
transferred to -80ºC until used. Tissue will be thawed and homogenized, then the cells
lysed and the lysate diluted. RNA will be purified using an Oligotex Direct mRNA kit. In
separate assays, primers specific to mRNA for ERα, ERβ, and GPR30 will be used in
RT-qPCR to amplify and quantify these mRNAs in the tissue homogenate.
Week

11

32 animals arrive

All animals weighed daily
Standard weight animals fed Purina 5TJS, 5% fat chow
Diet-induced obese animals fed Purina 5TJN, 20% fat chow

16 - Standard weight
16 - Diet-induced obese

12

All animals euthanized

Abdominal fat pad
Dissected, weighed, flash
frozen

Brains

ELISA or alternative assay
for aromatase

Blood
Collected in EDTA coated
tubes, centrifuged; plasma
aliquoted and frozen
ELISA for testosterone

Hippocampus and
hypothalamus rapidly
dissected and flash
frozen

ELISAs for
estradiol and
estrone

Amygdala, hippocampus,
and medial basal
hypothalamus rapidly
dissected, treated with
RNAlater, and frozen

ELISAs for estradiol and estrone

RT-qPCR for
mRNA for ERα,
ERβ, and GPR30

Figure 9. Experimental design for proposed experiments examining the effects of
adiposity on: peripheral levels of testosterone, aromatase, estradiol, and estrogen; central
levels of estradiol and estrogen; and ERα, Erβ, and GPR30.
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Limitations and future directions
The experiments above contain limitations, but also avenues for expansion and
extension in new directions. One of the most difficult limitations is that the accuracy of
estrogen ELISAs in detecting physiological levels of estrogens is unreliable at best.
Because of this limitation, exact results from individual samples will be examined not for
statistical differences but for trends in differences between groups. While this limits
analysis of estrogen levels, techniques using mass spectrometry to assay estradiol are
becoming more accessible and might soon allow for more accurate measurements. When
looking towards future directions the first step would be to repeat the above experiments
using peripubertally stressed mice, rather than diet-induced obese mice. Some of these
analyses could be performed using blood and brains collected from animals from the
experiments described in Chapters 2 and 3. Not only could similar analyses be performed
on those tissues are were performed in this section to further support these results, but the
brains could also be examined for more region specific mRNA expression of estrogen
receptors using either in situ hybridization or by further RT-qPCR of micropunches.
Additionally, studies of altered response to estradiol in depression- and anxiety- like
behaviors or in sexual receptivity or cognitive tasks should be carried out in animals with
diet-induced obesity. This would build not only on findings in peripubertally stressed
animals but also on studies of male diet-induced obesity mice which show increased
depression- and anxiety- like behaviors (Sharma & Fulton, 2012).
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APPENDIX
ADDITIONAL FIGURES
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Figure A.1. Percent change in bodyweight following peripubertal stressors for
Experiment 2. Error bars represent standard error of the means. Percent change in body
weight is calculated by subtracting the weight before treatment from the current weight,
then dividing by the weight before treatment. Note that for shipped animals, the initial
weight used is the weight of animals upon arrival; the weight gain experienced by these
animals results in a body weight which is not different from the saline or LPS animals
until after P63.
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Figure A.2. Sickness behavior for Experiment 2 scored on a three-point scale for the
saline and LPS injected groups at four time points following injection. Error bars
represent standard error of the means. Sickness behavior scores for LPS treated animals
were lower, and decreased more quickly than has been seen previously in C57Bl/6
(Ismail et al., 2013; Olesen et al., 2011).
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Figure A.3. Lordosis quotients for all treatment groups across five weeks of sexual
receptivity testing for Experiment 2. Error bars represent standard error of the means.
There were no effect of treatment, week of testing, or interaction on lordosis quotient.
Lordosis quotients were far lower and showed much greater variability than seen
previously in C57Bl/6 (Laroche et al., 2009a, 2009b).
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